ABIGAIL PUMM: Open Payments
NPI 1306573043 · NUTLEY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,610 in 224 payments from 20 companies in 2025. Trend: 2023 $1,866 · 2024 $3,602 · 2025 $3,610
Food & beverage: $3,505Education: $105
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 43 | $794 |
| ABBVIE INC. | 49 | $656 |
| Amgen Inc. | 24 | $315 |
| LEO Pharma Inc. | 12 | $315 |
| Janssen Biotech, Inc. | 12 | $270 |
| PFIZER INC. | 10 | $184 |
| Lilly USA, LLC | 13 | $169 |
| E.R. Squibb & Sons, L.L.C. | 14 | $153 |
| Regeneron Healthcare Solutions, Inc. | 10 | $151 |
| Organon LLC | 12 | $128 |
Products named: OPZELURA, SKYRIZI, Otezla, TREMFYA, CIBINQO, RINVOQ, DUPIXENT, ADBRY.
Industry payments across NJ — which companies pay providers there.
